MSB 3.11% $1.09 mesoblast limited

Ann: Partnership For Allogeneic Cell-based Cancer Immunotherapies, page-30

  1. 349 Posts.
    lightbulb Created with Sketch. 7
    Mesoblast has done a lot research and trials relating to blood cancers, through the use of extracting adult stem cells from bone marrow.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
-0.035(3.11%)
Mkt cap ! $1.255B
Open High Low Value Volume
$1.12 $1.13 $1.09 $3.049M 2.770M

Buyers (Bids)

No. Vol. Price($)
23 72290 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 66666 21
View Market Depth
Last trade - 13.45pm 18/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.